Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy.

Yang, Wen-Hsuan, Qiu, Yijian, Stamatatos, Olivia, Janowitz, Tobias, Lukey, Michael J (May 2021) Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy. Trends in Cancer. ISSN 2405-8033

URL: https://www.ncbi.nlm.nih.gov/pubmed/34020912
DOI: 10.1016/j.trecan.2021.04.003


Glutamine metabolism is reprogrammed during tumorigenesis and has been investigated as a promising target for cancer therapy. However, efforts to drug this process are confounded by the intrinsic metabolic heterogeneity and flexibility of tumors, as well as the risk of adverse effects on the anticancer immune response. Recent research has yielded important insights into the mechanisms that determine the tumor and the host immune responses to pharmacological perturbation of glutamine metabolism. Here, we discuss these findings and suggest that, collectively, they point toward patient stratification and drug combination strategies to maximize the efficacy of glutamine metabolism inhibitors as cancer therapeutics.

Item Type: Paper
Subjects: organs, tissues, organelles, cell types and functions > organs types and functions > metabolism
diseases & disorders > cancer > drugs and therapies > tumor microenvironment
CSHL Authors:
Communities: CSHL labs > Janowitz lab
CSHL labs > Lukey lab
SWORD Depositor: CSHL Elements
Depositing User: CSHL Elements
Date: 18 May 2021
Date Deposited: 26 May 2021 14:39
Last Modified: 09 May 2022 13:18
PMCID: PMC9064286
Related URLs:
URI: https://repository.cshl.edu/id/eprint/40167

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving